publicity, page-2

re: publicity/should move it

yes, hopefully slt gets a wriggle on tomorrow as the market factors in the revenues hep a and c rapid test kits would produce. this deal shows that seleect's technology is world class and should ensure success with their other ventures (including antigen research which represents the bonus steak knifes with this company) hep c is also one of the western world's growing and costly problems and a rapid test kit for it could well end up being government subsidised.

should see .40 soon, and revisit those highs when/if new deals come to fruition.